The relationship between C-reactive protein and the lapse of time since the onset of the symptoms after acute myocardial infarction: an prospective-observational study
The difference among the means of the G1-G3 (p=0.002), G1-G4 (p
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objective: It is important to know the elapsed symptom-to-door (StD) time between the emergence of ST-elevation myocardial infarction (STEMI) symptoms and admission to the hospital in terms of the selection of appropriate treatment and prognosis.
📊
Key Findings & Data:In this study, we aimed to assess the relationship between serum C-reactive protein (CRP) and StD time after STEMI.Methods: 436 of the patients admitted to our center with STEMI between August 2012-February 2013 (338 male, mean age, 63.9±12.8) were included in this prospective-observational cohort study.
💡
Conclusion & Impact:The difference among the means of the G1-G3 (p=0.002), G1-G4 (p
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters
Abstract
Objective: It is important to know the elapsed symptom-to-door (StD) time between the emergence of ST-elevation myocardial infarction (STEMI) symptoms and admission to the hospital in terms of the selection of appropriate treatment and prognosis. In this study, we aimed to assess the relationship between serum C-reactive protein (CRP) and StD time after STEMI.Methods: 436 of the patients admitted to our center with STEMI between August 2012-February 2013 (338 male, mean age, 63.9±12.8) were included in this prospective-observational cohort study. Blood samples were obtained from laboratory results of the first reference period. Patients were divided into four groups according to the duration of StD time [0-1. hour; group 1 (G1), 1-3. hour; group 2 (G2), 3-6. hour; group 3 (G3), 6-12. hour; group 4 (G4)]. Statistical analysis was performed via chi-squre test, ANOVA test, Pearson's correlation analysis and receiver operator charecteristic (ROC) analysis.Results: As the time progressed, an increase in CRP levels was observed. The difference among the means of the G1-G3 (p=0.002), G1-G4 (p
🔖
Cite This Article
GÜL, İ., AYKAN, A. Ç., GÖKDENİZ, T., BOYACI, F., KALAYCIOĞLU, E., HATEM, E., BİLGİN, M., ÇELİK, Ş. (2022). The relationship between C-reactive protein and the lapse of time since the onset of the symptoms after acute myocardial infarction: an prospective-observational study. Anadolu Kardiyoloji Dergisi, Cilt: 14 - Sayı: 7, 599–605. https://ajindex.com/articles/436061
Hunink MG, Goldman L, Tosteson AN, Mittleman MA, Goldman PA, Williams LW, et al. The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment. JAMA 1997
[Crossref] 2. Tunstall-Pedoe H, Kuulasmaa K, Mähönen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999
[Crossref] 3. Waller BF. Non atherosclerotic coronary heart disease. In: Fuster V, Alexander RW, O Rourke RA, editors. Hurst's the heart. 10th ed. McGraw-Hill
p.1161-205. 4. de Bono DP, Bhattacharrya AK. Segmental analysis of coronary arterial stenoses in patients presenting with angina or first myocardial infarction. Int J Cardiol 1991
[Crossref] 5. Brunetti ND, Troccoli R, Correale M, Pellegrino PL, Di Biase M. C-reactive protein in patients with acute coronary syndrome: correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings. Int J Cardiol 2006
[Crossref] 6. Aoki S, Nakagomi A, Asai K, Takano H, Yasu-take M, Seino Y, et al. Elevated peripheral blood mononuclear cell count is an independent predictor of left ventricular remodeling in patients with acute myocardial infarction. J Cardiol 2011
[Crossref] 7. Ridker PM. Clinical application of C-reactive protein for Cardiovascular disease detection and prevention. Circulation 2003
[Crossref] 8. Gökdemir MT, Kaya H, Söğüt O, Kaya Z, Albayrak L, Taşkın A. The role of oxidative stress and inflammation in the early evaluation of acute non-ST-elevation myocardial infarction: an observational study. Anadolu Kardiyol Derg 2013
Roubille F, Cayla G, Picot MC, Pradet V, Massin F, Gervasoni R, et al. C-reactive protein (CRP) after revascularized STEMI: is CRP a prognostic factor?. Rev Med Interne 2008
[Crossref] 10. Sima AV, Stancu CS, Simionescu M. Vascular endothelium in atherosclerosis. Cell Tissue Res 2009
[Crossref] 11. Calabro P, Willerson JT, Yeh ET. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 2003
[Crossref] 12. Antman EM, Morrow DA. ST-Segment elevation myocardial infarction management. In: Bonow RO, Mann DL, Zipe